Effect of Sugarcane Juice on Liver Patients
Launched by PIR MEHR ALI SHAH ARID AGRICULTURE UNIVERSITY · Aug 14, 2024
Trial Information
Current as of August 31, 2025
Completed
Keywords
ClinConnect Summary
This randomized controlled trial (RCT) is designed to evaluate the impact of sugarcane juice on liver health in patients diagnosed with liver-related conditions, including cirrhosis, hepatitis, and fatty liver disease. The study aims to assess whether sugarcane juice, administered in varying dosages, has a therapeutic effect on liver enzyme levels and overall liver function.
Study Design
This is an interventional study using a randomized controlled trial (RCT) design. Participants will be randomly assigned to one of four groups: three treatment groups and one control group. The treatment ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with liver disease, Age group 20 to 60years Symptoms criteria based on liver disease include jaundice, abdominal pain, fatigue, nausea, and elevated liver enzymes (ALT, AST) as per standard diagnostic criteria.
- Exclusion Criteria:
- • Patients younger than 20 years or older than 60 years. Pregnant or breastfeeding women Patients who have undergone liver transplantation. Patients with a history of other chronic conditions that may interfere with liver function, such as chronic kidney disease or heart failure.
About Pir Mehr Ali Shah Arid Agriculture University
Pir Mehr Ali Shah Arid Agriculture University is a distinguished research institution dedicated to advancing agricultural sciences and promoting sustainable practices in arid and semi-arid regions. With a commitment to innovative research and development, the university plays a pivotal role in addressing the challenges of food security, resource management, and environmental sustainability. Through its clinical trials, the university seeks to explore new agricultural methodologies, enhance crop resilience, and improve overall agricultural productivity, thereby contributing to the well-being of local communities and the broader agricultural sector.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rawalpindi, Punjab, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported